Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stevanato Group S.p.A (STVN) Operating Leases (2020 - 2025)

Stevanato Group S.p.A (STVN) reported Operating Leases of $10.9 million for Q4 2025, down 39.56% year-over-year from $18.1 million in Q4 2024, and down 39.56% on a QoQ basis from $18.1 million in Q4 2024.

Stevanato Group S.p.A (STVN) has 6 years of Operating Leases data on file, last reported at $10.9 million in Q4 2025.

  • Quarterly Operating Leases fell 39.56% year-over-year to $10.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.9 million (down 39.56% YoY) and the FY2025 annual result came in at $10.9 million, down 39.56% from the prior year.
  • Operating Leases fell to $10.9 million in Q4 2025 per STVN's latest filing, from $18.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $26.5 million in Q4 2021 and bottomed at $10.9 million in Q4 2025.
  • The 5-year median for Operating Leases is $20.4 million (2023), against an average of $19.2 million.
  • The widest annual swing landed in 2023, when Operating Leases decreased 0.01%; it then sank 39.56% in 2025.
  • Tracing STVN's Operating Leases over 5 years: stood at $26.5 million in 2021, then declined by 22.94% to $20.4 million in 2022, then fell by 0.01% to $20.4 million in 2023, then declined by 11.4% to $18.1 million in 2024, then slumped by 39.56% to $10.9 million in 2025.
  • Per Business Quant, the three latest STVN Operating Leases figures stand at $10.9 million (Q4 2025), $18.1 million (Q4 2024), and $20.4 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 10.92 Mn
Dec 31, 2024 18.06 Mn
Dec 31, 2023 20.38 Mn
Dec 31, 2022 20.39 Mn
Dec 31, 2021 26.46 Mn
Dec 31, 2020 30.55 Mn